De Fauw, Jeffrey
Ledsam, Joseph R.
Romera-Paredes, Bernardino
Nikolov, Stanislav
Tomasev, Nenad
Blackwell, Sam
Askham, Harry
Glorot, Xavier
O’Donoghue, Brendan
Visentin, Daniel
van den Driessche, George
Lakshminarayanan, Balaji
Meyer, Clemens
Mackinder, Faith
Bouton, Simon
Ayoub, Kareem
Chopra, Reena http://orcid.org/0000-0002-4264-8329
King, Dominic
Karthikesalingam, Alan
Hughes, Cían O. http://orcid.org/0000-0001-6901-0985
Raine, Rosalind
Hughes, Julian
Sim, Dawn A.
Egan, Catherine
Tufail, Adnan
Montgomery, Hugh http://orcid.org/0000-0001-8797-5019
Hassabis, Demis
Rees, Geraint http://orcid.org/0000-0002-9623-7007
Back, Trevor
Khaw, Peng T.
Suleyman, Mustafa
Cornebise, Julien
Keane, Pearse A. http://orcid.org/0000-0002-9239-745X
Ronneberger, Olaf http://orcid.org/0000-0002-4266-1515
Article History
Received: 19 December 2017
Accepted: 1 June 2018
First Online: 13 August 2018
Competing interests
: P.A.K., G.R., H.M. and R.R. are paid contractors of DeepMind. P.A.K. has received speaker fees from Heidelberg Engineering, Topcon, Haag-Streit, Allergan, Novartis and Bayer. P.A.K. has served on advisory boards for Novartis and Bayer, and is an external consultant for DeepMind and Optos. A.T. has served on advisory boards for the following companies: Allergan, Bayer, Genentech, GlaxoSmithKline, Novartis, Roche. C.E. has received speaker fees from Heidelberg Engineering and Haag-Streit UK. P.T.K. has served on advisory boards for Aerie, Allergan, Alcon, Belkin Laser, Novartis and Santen. D.A.S. has received speaker fees from Novartis, Bayer, Allergan, Haag-Streit. The authors have no other competing interests to disclose.